EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / ...
EQS-News: Marinomed Biotech AG / Key word (s): Insolvency/Restructure of Company Marinomed Biotech AG: Restructuring proceedings successfully completed 20.01.2025 / 07:45 CET/CEST The issuer is ...
Regulatory ApprovalFormycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / 06:30 CET/CESTThe issuer is solely ...
EQS-News: Marinomed Biotech AG / Key word (s): Insolvency/Restructure of Company Marinomed Biotech AG: Restructuring proceedings successfully completed 20.01.2025 / 07:45 CET/CEST The issuer is ...
The Mercedes EQS saloon boasts the highest range of any EV on sale in the UK today, with a claimed figure of 481 miles when equipped with its huge 118kWh battery. It's helped significantly by its ...
HOUSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Equus Total Return, Inc. (NYSE: EQS) (“Equus” or the “Fund”) today announces that Fraser Atkinson has been appointed as the Fund’s independent ...